The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate ...
Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Sept. 25 (UPI) --Researchers have succeeded in creating a digital twin that for the first time replicates the heart's electrical conduction system, which coordinates heartbeats, a new study says. The ...
DANVILLE, Pa. — Geisinger Health System's team of electrophysiologists is researching and implementing the latest techniques to treat patients with heart arrhythmia. "We've had many physicians come ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecure™ defibrillation lead. Now ...
DALLAS, Oct. 31, 2022 — Heart rhythm measures in the electrocardiograms of the first pig-to-human heart transplant found unexpected differences in the electrical conduction system of the genetically ...
Electrical problems in the heart can often lead to serious and fatal complications including complete heart block or heart failure. Left ventricular conduction disease occurs when there is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results